Genome Group Rips Human Cloning Scientists at the Human Genome Organization have condemned plans for human cloning, saying it raises […]

As Pipelines Wither, Pharma and FDA Explore Whether Microarrays are Ready for Primetime When can the pharmaceutical industry start trusting

Research ‘leak’ hits Genentech Genentech’s shares dropped 12.5 per cent after details of the biotechnology company’s research abstracts for next

Research ‘leak’ hits Genentech Genentech’s shares dropped 12.5 per cent after details of the biotechnology company’s research abstracts for next

As Tony White Reads Resumes, Industry Buzzes Around Core Four It’s been two-and-a-half months since J. Craig walked away from

President Presses Senate to Ban All Human Cloning Declaring that “life is a creation, not a commodity,” Bush pressed the

7 drug makers unveil elderly discounts Under pressure from consumers and lawmakers over drug prices, Abbott Laboratories and six other

Survival of fittest is new mode for biotechs Consolidation won’t slow, and that’s no bad thing, industry watchers say

Biotech booster shot Sector, regional economy stand to gain key ally as Harvard makes gesture to loosen its strained ties

Bad Genes, Good Drugs Wondering what happened to all that knowledge we got from mapping the human genome?